GLP-1 receptor agonists not only reduce appetite but also reshape food preferences, shedding light on the neural mechanisms underlying compulsive consumption and offering potential therapeutic avenues for metabolic and behavioral disorders. Here, GLP1R is linked to Atypical behavior.